Display Settings:


Send to:

Choose Destination
Clin Exp Immunol. 2012 Apr;168(1):24-9. doi: 10.1111/j.1365-2249.2011.04556.x.

Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function.

Author information

  • 1Diabetes Unit, Dept. of Internal Medicine, Endocrine and Metabolic Sciences and Biochemistry, University of Siena, Viale Bracci 18, Siena, Italy.


Type 1 diabetes mellitus (T1DM) is a multi-factorial immune-mediated disease characterized by the autoimmune destruction of insulin-producing pancreatic islet beta cells in genetically susceptible individuals. Epidemiological evidence has also documented the constant rise in the incidence of T1DM worldwide, with viral infections representing one of the candidate environmental risk factors identified by several independent studies. In fact, epidemiological data showed that T1DM incidence increases after epidemics due to enteroviruses and that enteroviral RNA can be detected in the blood of >50% of T1DM patients at the time of disease onset. Furthermore, both in-vitro and ex-vivo studies have shown that viruses can infect pancreatic beta cells with consequent effects ranging from functional damage to cell death.

© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.

[PubMed - indexed for MEDLINE]
Free PMC Article

Images from this publication.See all images (3)Free text

Fig. 1
Fig. 2
Fig. 3
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing Icon for PubMed Central
    Loading ...
    Write to the Help Desk